Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Intangibles (2016 - 2025)

Historic Intangibles for Dexcom (DXCM) over the last 10 years, with Q4 2025 value amounting to $70.8 million.

  • Dexcom's Intangibles fell 3152.8% to $70.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $70.8 million, marking a year-over-year decrease of 3152.8%. This contributed to the annual value of $70.8 million for FY2025, which is 3152.8% down from last year.
  • According to the latest figures from Q4 2025, Dexcom's Intangibles is $70.8 million, which was down 3152.8% from $79.0 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Intangibles ranged from a high of $173.3 million in Q4 2022 and a low of $24.4 million during Q3 2022
  • Moreover, its 5-year median value for Intangibles was $103.4 million (2024), whereas its average is $97.9 million.
  • Per our database at Business Quant, Dexcom's Intangibles skyrocketed by 49221.31% in 2023 and then tumbled by 3152.8% in 2025.
  • Over the past 5 years, Dexcom's Intangibles (Quarter) stood at $31.5 million in 2021, then soared by 450.16% to $173.3 million in 2022, then fell by 22.39% to $134.5 million in 2023, then dropped by 23.12% to $103.4 million in 2024, then plummeted by 31.53% to $70.8 million in 2025.
  • Its Intangibles stands at $70.8 million for Q4 2025, versus $79.0 million for Q3 2025 and $87.2 million for Q2 2025.